Document is current
Any future updates will be listed below
-
Authors
Kleinman, Robert A.
Rashad, Wegdan
-
Funding
Funding for this research was provided by:
Centre for Addiction and Mental Health Foundation
Department of Psychiatry, University of Toronto
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 19 December 2025
First Online: 30 January 2026
Declarations
:
: This study was deemed exempt from review by the Centre for Addiction and Mental Health Research Ethics Board.
: Dr. Kleinman reports personal equity holdings in Novo Nordisk and Pfizer. There are no other conflicts of interest.
